UC Cancer Research Initiatives Receive $132,000 Boost
Published August 2007
Cancer research initiatives at UC have received a $132,000 boost from Ride Cincinnati, a local nonprofit organization dedicated to generating funds for breast cancer research.
Ride Cincinnati recently presented the UC Barrett Cancer Center at University Hospital with a check for the $132,000 raised at its first cycling event, known by the same name. The event, which is expected to become an annual event, was held June 10 at Yeatman’s Cove and included more than 950 cyclists of all ages.
Initial funds will establish the Marlene Harris–Ride Cincinnati Breast Cancer Pilot Grant Program at UC, which will be used to increase local breast cancer research and encourage collaboration between basic science and clinical investigators.
“Through her 15 years of fighting breast cancer, Marlene remained dedicated to helping find a cure through research,” says Harvey Harris, DDS, whose late wife inspired the event. “We hope this money can serve as a catalyst for bringing together investigators who are able to translate laboratory findings into clinical interventions that benefit patients.”
The newly established fund will provide three $40,000 grants to young scientists annually.
“We are thrilled with the Ride Cincinnati volunteer team’s efforts to raise much-needed funds for breast cancer research in Cincinnati,” said David Stern, MD, interim director of the Barrett Cancer Center and dean of the College of Medicine. “Community support from events like this fills the gaps in funding for young researchers and helps us continue to push science forward.”
UC recently signed a memorandum of understanding with Cincinnati Children’s Hospital Medical Center and University Hospital to create a joint cancer center to enhance and coordinate oncology care from childhood to adulthood in southern Ohio and beyond.
This strategic partnership also will provide the scientific and intellectual resources to enable the three institutions to increase their internationally significant research.